Arbor Assays

Executive Summary

Arbor Assays is a privately held, employee-owned biotechnology company headquartered in Ann Arbor, Michigan, specializing in the development and manufacture of high-quality immunoassay kits and reagents for life science research. Founded in 2007, the company has built a reputation for providing reliable, easy-to-use tools that support scientists in diverse fields including endocrinology, metabolism, and neuroscience. Its product portfolio includes competitive and sandwich ELISA kits, as well as custom assay development services. Arbor Assays differentiates itself through a customer-centric approach, offering technical support and flexible ordering options. As an employee-owned organization, the company fosters a culture of innovation and accountability, which has enabled steady growth in the fragmented assay kit market. While relatively small, Arbor Assays benefits from recurring revenue from academic and biopharma customers and maintains a lean operational structure. The company does not disclose financials, but its longevity and employee ownership model indicate sustainable performance.

Upcoming Catalysts (preview)

• Q3 2026Launch of Novel Assay Kits for Neurodegenerative Disease Biomarkers70% success
• Q4 2026Strategic Distribution Partnership in Asia-Pacific Region50% success
• H1 2027Release of Custom Assay Development Service for Biopharma Clients60% success